SCHEMBL26458556

SCHEMBL26458556

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3C3(c5ccccc5Oc5ccccc53)c3cc(-c5cnc6ccccc6n5)ccc3-4)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.42
RAB9A P51151 10/20 0.42
KMT2A Q03164 5/20 0.40
JAK2 O60674 2/20 0.39
SMN1; SMN2 Q16637 4/20 0.36
TP53 P04637 1/20 0.36
STAT1 P42224 1/20 0.36
BCHE P06276 1/20 0.36
PDGFRB P09619 1/20 0.36
KDR P35968 1/20 0.36
FLT3 P36888 1/20 0.36
MEN1 O00255 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ESR1 P03372 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26458393 0.94 NPC1 (0.38) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458485 0.93 NPC1 (0.44) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458337 0.91 NPC1 (0.43) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458606 0.90 NPC1 (0.39) NPC1RAB9AKMT2AJAK2SMN1; SMN2
SCHEMBL26458398 0.88 MEN1 (0.36) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL26458564 0.87 MEN1 (0.44) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL22216542 0.87 PDK2 (0.39) KMT2AMEN1KDM4EMAPT
SCHEMBL22216511 0.87 PDK2 (0.39) KMT2AMEN1KDM4EMAPT
SCHEMBL26458425 0.87 PDK2 (0.36) NPC1RAB9AKMT2ASMN1; SMN2MEN1
SCHEMBL26458598 0.87 PDK2 (0.39) KMT2AMEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641778-B2 Compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641778-B2 Compound and organic light emitting device comprising same CRY1, CYP1A1, CRY2 NPC1 1521/4885RAB9A 2344/4885KMT2A 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.